Physician profile
Ryan S Ferrell
NPI 1891805933
$2,070.69
in general payments reported to CMS, 2019-2025
19 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.12 · 2020: $47.48 · 2021: $183 · 2022: $157 · 2023: $540 · 2024: $604 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,636.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $658.54 | 2019-2025 | Watchman Access System, Farapulse, Watchman Flx |
| Amgen INC. | $358.03 | 2020-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $335.18 | 2022-2025 | Camzyos, Eliquis |
| Pfizer INC. | $170.84 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $89.26 | 2019-2024 | Lifevest |
| Novo Nordisk INC | $61.90 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $50.41 | 2022-2025 | Verquvo |
| Abiomed | $48.86 | 2023-2025 | Impella |
| Kiniksa Pharmaceuticals International, Plc | $43.95 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $41.08 | 2022-2023 | Optimizer |
| Alnylam Pharmaceuticals INC. | $35.85 | 2025 | Onpattro |
| Astrazeneca Pharmaceuticals LP | $33.04 | 2022-2023 | |
| Irhythm Technologies, INC. | $30.43 | 2024 | Zio Monitor, Zio Xt Patch |
| Novartis Pharmaceuticals Corporation | $28.66 | 2019-2024 | |
| Scpharmaceuticals INC. | $24.91 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $15.86 | 2020 | |
| Medtronic, INC. | $15.83 | 2023 | Cobalt Dr Mri Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.71 | 2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $13.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Ferrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.